Biogen Inc (NASDAQ:BIIB) over-valued by 21%
| Website | https://www.biogen.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $42,418,872,320 |
| Beta | 0.436845 |
| Average Volume | $1,088,167 |
| Last Dividend | 0% |
| Price on Jul 20, 2022 | $276.61 |
| Autochartist™ Valuation | $218.53 |
| Conclusion |
21% over-valued |
| Download Report |
